Medication adherence
PDC is decided at home, one dose at a time.
A mechanical cap for Medicare adherence — and only a plan that dispenses its own prescriptions can run it.
A reminder built into the bottle, not around it.
The plan can pay for the fill. It cannot be there for the dose.
Close the bottle and the day advances one position, so the next dose is visible at the point of action. No app, no battery, no connectivity — nothing to integrate, and no new data to secure.
How the measure is scored
Triple-weighted, and graded against the field.
A competitor’s adherence gain is your loss.
The three Part D adherence measures each carry a weight of 3 for the 2026 Star Ratings. For a Medicare Advantage plan with drug coverage they feed the overall contract rating — the rating the quality bonus turns on. The threshold is set by where everyone else lands, so when other plans improve and yours holds, the bar moves and the star falls.
Operational fit
It goes on at a step you already own.
A supply change, not a program launch. It is a closure, not a package — a continuous-thread cap compatible with industry-standard prescription vials and with high-speed filling and capping equipment, in place of your current closure.
The model
We license the mechanism. You supply the caps.
Multiple granted patents, in force, across separate priority dates — the newest currently runs to 2038.
Produced by whoever already makes the closures your pharmacy buys.
Evidence
A clean read on your own members.
The randomized evidence for reminder devices was built in commercially insured members aged 18 to 64. Medicare beneficiaries were excluded by design, so this has never been tested in the population you are scored on.
A matched cohort in your own pharmacy would settle it, on the PDC you already compute. Every fill gets a cap, no selection bias.
Next step
Worth a conversation.
The mechanism is available to license. What a plan can do with it is the opportunity, and that is the conversation.